NICE PH52 Guidance
To ensure our products are best suited for use in the harm reduction market, Vernacare develop their products and services in accordance with NICE guidance (PH52). Our products and services aim to reduce the transmission of bloodborne viruses and other infections, such as HIV, Hepatitis B and C, caused by the sharing on injecting equipment. Ultimately, reducing the strain on public health and wider society.
We offer a range of ID and colour-coded injecting equipment, in order to make equipment easily identifiable and therefore reduce the risk of sharing. Vernacare’s offer LDS harm reduction solutions that minimizing the risks associated with injecting drugs.